These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 40694)

  • 1. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Prog Clin Biol Res; 1981; 75A():391-407. PubMed ID: 7339627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of estramustine, a nitrogen mustard derivative of estradiol-17 beta, in cytosol from rat ventral prostate.
    Forsgren B; Högberg B; Gustafsson JA; Pousette A
    Acta Pharm Suec; 1978; 15(1):23-32. PubMed ID: 645366
    [No Abstract]   [Full Text] [Related]  

  • 4. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estramustine-binding protein in rat and human prostate.
    Forsgren B
    Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the estramustine-binding protein in rat ventral prostate and in human prostate.
    Gustafsson JA; Björk P; Carlström K; Forsgren B; Hökfelt T; Pousette A; Högberg B
    Scand J Urol Nephrol Suppl; 1980; 55():133-4. PubMed ID: 6163205
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of Estracyt in Japan.
    Yamanaka H; Imai K; Yuasa H; Shida K
    Prostate; 1981; Suppl 1():95-102. PubMed ID: 7043423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of estramustine in rat ventral prostate following intravenous injection.
    Peterson C; Forsgren B; Högberg B
    Acta Physiol Scand Suppl; 1983; 515():55-63. PubMed ID: 6578672
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of sex hormones on prostatic secretion protein, a major protein in rat prostate.
    Pousette A; Björk P; Carlström K; Forsgren B; Högberg B; Gustafsson JA
    Cancer Res; 1981 Feb; 41(2):688-90. PubMed ID: 7448814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3149-53. PubMed ID: 290993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogen-binding proteins in the rat ventral prostate: specific and nonspecific high-affinity binding sites for benzo(a)pyrene, 3-methylcholanthrene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Söderkvist P; Poellinger L; Gustafsson JA
    Cancer Res; 1986 Feb; 46(2):651-7. PubMed ID: 3940634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P; Jönsson U; Andrén-Sandberg A
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of steroidal alkylating agents with binding components in the soluble fraction of the prostate.
    Högberg B; Björk P; Carlström K; Forsgren B; Gustafsson JA; Hökfelt T; Pousette A
    Prog Clin Biol Res; 1979; 33():181-99. PubMed ID: 531044
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific binding of estramustine to prostatic proteins.
    Forsgren B; Björk P
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoradiographic studies of 3H-estramustine in the rat ventral prostate.
    Appelgren LE; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):368-74. PubMed ID: 726901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
    Hoisaeter PA
    Invest Urol; 1976 Sep; 14(2):85-92. PubMed ID: 972011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic aspects and actions unique to Estracyt.
    Sandberg AA
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of androgen receptor and estramustine binding protein of rat ventral prostatic tissue in organ culture.
    Høisaeter PA; Kadohama N; Corrales JJ; Karr JP; Murphy GP; Sandberg AA
    J Steroid Biochem; 1981 Mar; 14(3):251-60. PubMed ID: 7218791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.